Phibro Animal Health (NASDAQ:PAHC) Stock Price Up 6.8% on Analyst Upgrade

Phibro Animal Health Co. (NASDAQ:PAHC)’s stock price rose 6.8% during mid-day trading on Monday after Barclays raised their price target on the stock from $20.00 to $22.00. Barclays currently has an underweight rating on the stock. Phibro Animal Health traded as high as $24.21 and last traded at $25.30. Approximately 92,480 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 154,656 shares. The stock had previously closed at $23.69.

Several other research firms have also issued reports on PAHC. StockNews.com lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Morgan Stanley lifted their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Phibro Animal Health presently has an average rating of “Hold” and an average price target of $21.00.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Hussman Strategic Advisors Inc. bought a new stake in shares of Phibro Animal Health in the 4th quarter worth approximately $2,205,000. Jacobs Levy Equity Management Inc. raised its stake in Phibro Animal Health by 116.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock valued at $4,330,000 after buying an additional 103,491 shares during the last quarter. Algert Global LLC raised its stake in Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after buying an additional 59,850 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in Phibro Animal Health during the 4th quarter valued at $1,103,000. Finally, Wakefield Asset Management LLLP purchased a new stake in Phibro Animal Health during the 4th quarter valued at $1,020,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Price Performance

The company has a current ratio of 3.20, a quick ratio of 1.69 and a debt-to-equity ratio of 2.99. The stock has a market capitalization of $1.03 billion, a PE ratio of 53.27, a price-to-earnings-growth ratio of 0.53 and a beta of 0.52. The firm has a 50 day moving average price of $21.90 and a 200 day moving average price of $21.70.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Research analysts anticipate that Phibro Animal Health Co. will post 1.94 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 1.88%. Phibro Animal Health’s payout ratio is presently 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.